Next Article in Journal
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study
Next Article in Special Issue
Equal Maintenance of Anti-SARS-CoV-2 Antibody Levels Induced by Heterologous and Homologous Regimens of the BNT162b2, ChAdOx1, CoronaVac and Ad26.COV2.S Vaccines: A Longitudinal Study Up to the 4th Dose of Booster
Previous Article in Journal
Safety and Efficacy of Antiviral Drugs and Vaccines in Pregnant Women: Insights from Physiologically Based Pharmacokinetic Modeling and Integration of Viral Infection Dynamics
Previous Article in Special Issue
Safety, Immunogenicity, and Effectiveness of Chinese-Made COVID-19 Vaccines in the Real World: An Interim Report of a Living Systematic Review
 
 
Article

Article Versions Notes

Vaccines 2024, 12(7), 783; https://doi.org/10.3390/vaccines12070783
Action Date Notes Link
article xml file uploaded 16 July 2024 14:09 CEST Original file -
article xml uploaded. 16 July 2024 14:09 CEST Update https://www.mdpi.com/2076-393X/12/7/783/xml
article pdf uploaded. 16 July 2024 14:09 CEST Version of Record https://www.mdpi.com/2076-393X/12/7/783/pdf
article html file updated 16 July 2024 14:11 CEST Original file https://www.mdpi.com/2076-393X/12/7/783/html
Back to TopTop